Potential biochemical therapy of glioma cancer

Biochem Biophys Res Commun. 2007 Oct 19;362(2):225-9. doi: 10.1016/j.bbrc.2007.07.167. Epub 2007 Aug 8.

Abstract

Glioma is a highly invasive, rapidly spreading form of brain cancer that is resistant to surgical and medical treatment. The recent progresses made in intracellular and ion channels of glioma cells provide a potential new approach for biochemical therapy of brain tumor. In this paper, we reviewed clinical data on chemotherapy by temozolomide and results from new studies on voltage-gated potassium channels, large-conductance Ca(2+)-activated K(+) channels, volume-activated chloride channels, glioma-specific chloride channel and their modulators. These new findings may represent future directions for brain tumor studies and treatment.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents, Alkylating / therapeutic use
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / metabolism
  • Brain Neoplasms / pathology
  • Dacarbazine / analogs & derivatives*
  • Dacarbazine / chemistry
  • Dacarbazine / therapeutic use
  • Glioma / drug therapy*
  • Glioma / metabolism
  • Glioma / pathology
  • Humans
  • Indoles / chemistry
  • Indoles / therapeutic use
  • Models, Biological
  • Molecular Structure
  • Potassium Channel Blockers / therapeutic use
  • Potassium Channels, Calcium-Activated / antagonists & inhibitors
  • Potassium Channels, Calcium-Activated / metabolism
  • Temozolomide

Substances

  • Antineoplastic Agents, Alkylating
  • Indoles
  • Potassium Channel Blockers
  • Potassium Channels, Calcium-Activated
  • paxilline
  • Dacarbazine
  • Temozolomide